To RA patients like myself, drugs like Enbrel can feel like a miracle. Yes, we don’t want to rely on drugs, and, yes, there are side effects, and, sure, there are nasty warning labels. But the trade-off is life less limited by RA. Hope for a future that doesn’t include disability.

But that happily ever after is not the full story. Around 15-20% of Rheumatoid Arthritis patients have exhausted all the treatment options. The medications either result in too many side effects or become ineffective. For these patients, I imagine it feels like there’s not a lot of hope left.

A new drug just went through Phase 3 clinical trials that might offer these patients hope. Read more about it here.

http://scopeblog.stanford.edu/2016/03/28/unmasked-molecular-mechanism-of-rheumatoid-arthritis-revealed/